Open Orphan (ORPH)

Sector:

Health Care

Index:

FTSE AIM All-Share

5.78p
   
  • Change Today:
    -0.075p
  • 52 Week High: 8.00
  • 52 Week Low: 1.55
  • Currency: UK Pounds
  • Shares Issued: 254.03m
  • Volume: 904,893
  • Market Cap: £14.67m
  • RiskGrade: 194
  • Beta: 0.26

Latest ShareCast News

Open Orphan signs pharmacology trial contract with Carna

By Josh White

Date: Monday 18 Nov 2019

(Sharecast News) - Rare and orphan drug consulting services provider Open Orphan announced the signing of a contract with Carna Bioscience for a first-in-human clinical pharmacology trial, it announced on Monday.

Open Orphan inks preferred partner deal with Ipsen Group

By Josh White

Date: Monday 11 Nov 2019

(Sharecast News) - Europe-focussed rare and orphan drug consulting services platform Open Orphan announced the signing of a preferred partner agreement with Ipsen Group on Monday.

Open Orphan signs deal with Empiric Logic to complete Health Data platform

By Josh White

Date: Tuesday 15 Oct 2019

(Sharecast News) - Europe-focussed rare and orphan drug consulting services platform provider Open Orphan has signed a new strategic collaboration agreement with Empiric Logic, it announced on Tuesday, to build on the earlier work it had performed, and complete the build out of its 'Health Data' platform as Europe's first rare disease, advocacy-led genomic database.

Venn Life Sciences finds 'model client' in Carri... 18-Jan-2019 ShareCast
Venn Life Sciences shuffles board, partners with... 11-Dec-2018 ShareCast
Venn Life Sciences trades in line as it looks to... 15-Feb-2018 ShareCast
Venn Life Sciences revenues edge higher 20-Jul-2017 ShareCast
Venn Life Sciences' share surge after upbeat FY ... 03-Mar-2017 ShareCast
Venn Life Sciences completes £4.74m Innovenn sale 18-Nov-2016 ShareCast
Venn Life Sciences wins new contract worth EUR2.5m 08-Nov-2016 ShareCast
Director dealings: Venn Life Sciences chairman s... 02-Nov-2016 ShareCast
Venn Life Sciences shareholders approve sale of ... 27-Oct-2016 ShareCast
Venn Life Sciences to offload Innovenn UK 04-Oct-2016 ShareCast
Venn Life Sciences shares drop despite revenue r... 28-Sep-2016 ShareCast
Venn Life Sciences wins €2.8m contract 03-Aug-2016 ShareCast
Venn Life Sciences expecting revenues to double 08-Jan-2016 ShareCast
Venn Life Sciences signs EUR1m contract 23-Oct-2015 ShareCast
Venn Life posts narrow interim loss, acquires Ki... 22-Sep-2015 ShareCast
Venn Life Sciences reports strong first-half tra... 13-Aug-2015 ShareCast
Venn Life Sciences appoints new CFO 15-Jun-2015 ShareCast
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Open Orphan Market Data

Currency UK Pounds
Share Price 5.78p
Change Today -0.075p
% Change -1.28 %
52 Week High 8.00
52 Week Low 1.55
Volume 904,893
Shares Issued 254.03m
Market Cap £14.67m
Beta 0.26
RiskGrade 194

Open Orphan Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value Not Available
Price Trend
57.47% above the market average57.47% above the market average57.47% above the market average57.47% above the market average57.47% above the market average
43.59% above the sector average43.59% above the sector average43.59% above the sector average43.59% above the sector average43.59% above the sector average
Income Not Available
Growth
39.04% below the market average39.04% below the market average39.04% below the market average39.04% below the market average39.04% below the market average
47.06% below the sector average47.06% below the sector average47.06% below the sector average47.06% below the sector average47.06% below the sector average

Open Orphan Dividends

No dividends found

Trades for 06-Dec-2019

Time Volume / Share Price
16:10 370,000 @ 5.75p
16:26 100,000 @ 5.80p
15:13 38,655 @ 5.80p
15:13 43,103 @ 5.80p
15:10 100,000 @ 5.80p

Open Orphan Key Personnel

COO Christian Bernard Milla
CEO Cathal Friel

Top of Page